Results 231 to 240 of about 131,323 (382)

Synthesis, Anticonvulsant, Antinociceptive Activity and Preliminary Safety Evaluations of Novel Hybrid Imidazolidine‐2,4‐Dione Derivatives with Morpholine Moiety

Anna Czopek, Hanna Byrtus, Małgorzata Góra, Anna Rapacz, Kinga Sałat, Paulina Koczurkiewicz, Elżbieta Pękala, Jolanta Obniska, Krzysztof Kamiński   +8 more
openalex   +2 more sources

Pre-Hospital Midazolam for Treatment of Status Epilepticus Before and After the Rapid Anticonvulsant Medication Prior to Arrival Trial: A National Observational Cohort Study [PDF]

, 2016
Eytan Shtull‐Leber, Robert Silbergleit, William J. Meurer   +2 more
openalex   +1 more source

Physiologically based pharmacokinetic modeling and simulation of topiramate in populations with renal and hepatic impairment and considerations for drug–drug interactions

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 510-522, March 2025.
Abstract Topiramate (TPM) is a broad‐spectrum antiepileptic drug (AED) commonly prescribed for approved and off‐label uses. Routine monitoring is suggested for clinical usage of TPM in special population due to its broad side effect profile. Therefore, it is crucial to further explore its pharmacokinetic characteristics.
Shuqing Chen, Chaozhuang Shen, Yuchen Tian, Yuhe Peng, Jing Hu, Haitang Xie, Ping Yin   +6 more
wiley   +1 more source

Anticonvulsant Potential of 1-Aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines: Insights from Strychnine and Nicotine Models in In Vivo and In Silico Studies. [PDF]

Pharmaceuticals (Basel)
Azamatov AA, Mamadalieva NZ, Mandour AA, Zhurakulov SN, Aytmuratova UK, Vinogradova VI, Jalilov FS, Tursunkhodzhaeva FM.   +7 more
europepmc   +1 more source

Neural Correlates of Cognitive Improvement After Virtual Reality‐Based Cognitive Remediation in Psychosis and Mood Disorders: A Randomized Controlled Trial

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard, Andreas Elleby Jespersen, Ida Kruse Søndergaard, Anders Lumbye, Maj Vinberg, Louise Birkedal Glenthøj, Merete Nordentoft, Anjali Sankar, Gitte Moos Knudsen, Julian Macoveanu, Kamilla Woznica Miskowiak   +10 more
wiley   +1 more source

Persistently Elevated Gamma Power and Delayed Brain Damage in Aged Rats Acutely Exposed to Soman Without Status Epilepticus: Comparisons with Seizing Rats Treated with Midazolam or with Tezampanel and Caramiphen. [PDF]

Toxics
Figueiredo TH, Aroniadou-Anderjaska V, De Araujo Furtado M, Pidoplichko VI, Rossetti K, Lumley LA, Braga MFM.   +6 more
europepmc   +1 more source

Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants [PDF]

, 2017
Nathan P. Clark, Kim Hoang, Thomas Delate, John R. Horn, Daniel M. Witt   +4 more
openalex   +1 more source

Associations Between Cognitive Functions and Subsequent Mood Disorder Prognosis in Low‐Risk, High‐Risk and Affected Monozygotic Twins: A Seven‐Year Follow‐Up Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Aberrant cognition is common among individuals at familial risk for mood disorders (MD) and those already affected. However, long‐term prospective studies are needed to determine whether specific cognitive features predict illness onset and relapse; and whether cognitive impairments reflect neurodevelopmental traits or ...
Kamilla Miskowiak, Hanne Lie Kjærstad, Stella Lystlund, Anjali Sankar, Lars Kessing, Maj Vinberg   +5 more
wiley   +1 more source

An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Neurol Ther
Hubsch A, Divino V, Mallick R, Coyle KB, Langford E, Wang Y, Ida F, Lahue BJ, Zhang X.   +8 more
europepmc   +1 more source

Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism

British Journal of Pharmacology, 2013
T. Hill, M. Cascio, B. Romano, M. Duncan, R. Pertwee, C. Williams, Benjamin J. Whalley, A. Hill   +7 more
semanticscholar   +1 more source